Evidence map›Paper›PMID 29057810›Full record

ArticleMolecules (Basel, Switzerland)2017

Synthesis, Characterization, and Biological Evaluations of 1,3,5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium Methylate.

Han Cao, Shili Liao, Wenjing Zhong, Xuerong Xiao, Jiancheng Zhu, Weimin Li, Xia Wu, Yifan Feng

Open access · goldFull text read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Han CaoCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. caohan19930219@163.com.
Shili LiaoCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. shililiao_03@163.com.
Wenjing ZhongCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. ZWJzwj112@163.com.
Xuerong XiaoCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. x1784502739@163.com.
Jiancheng ZhuCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. edenss@foxmail.com.
Weimin LiCollege of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou 510000, China. 13925023915@139.com.
Xia WuCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. wxiaxia@163.com.
Yifan FengCentral Laboratory of Guangdong, Pharmaceutical University, Guangzhou 510000, China. yffeng@139.com.
Guangdong Pharmaceutical University · CNGuangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel target products were synthesized in the formation of a triazine ring from berberine, magnolol, and metformin catalyzed by sodium methylate. The structures of products

Indexed as

Anti-Inflammatory AgentsBerberineBiphenyl CompoundsCyclizationHumansInflammationInsulin ResistanceLignansMetforminMolecular StructureSodiumStructure-Activity RelationshipTriazinesAnti-Inflammatory AgentsBerberineBiphenyl CompoundsLignansmagnololMetforminSodiumTriazinesanti-inflammatory activityanti-insulin resistancecyclization triazine

Identifiers

PMID29057810
PMCPMC6151379
OpenAlexW2766534861

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.